NEW YORK, Jan. 26, 2026 /PRNewswire/ — Chaos Labs today launched Chaos Vaults, an AI-powered platform bringing a more disciplined, risk-aware approach to onchain yield for exchanges and institutions.
Chaos Vaults is now live on Kraken DeFi Earn, delivering real-time risk visibility and automated yield strategies to users across the U.S., Canada, and Europe.
The launch builds on Chaos Labs’ risk and data systems, which have powered more than $5 trillion in transaction volume across major onchain protocols, including Aave, Ethena, and Pendle.
Until now, exchanges and institutions have lacked a way to deploy onchain yield strategies with continuous risk controls and operational visibility at production scale. Chaos Vaults brings institutional discipline to vault design, aligning onchain yield with the operational expectations of large-scale capital allocators.
Chaos Vaults delivers the following capabilities:
“Chaos Vaults gives institutions a way to manage yield as markets evolve block by block,” said Omer Goldberg, Founder and CEO of Chaos Labs. “Launching with Kraken’s DeFi Earn puts this into production for millions of global users.”
“We built DeFi Earn to remove the friction that’s held DeFi back—no technical setup, no confusing workflows,” said John Zettler, Director of Product Management at Kraken. “By integrating risk-managed vaults from partners like Chaos Labs, we’re giving users a simple, transparent way to access real-world opportunities in today’s onchain markets.”
Learn more at chaoslabs.xyz/vaults
About Chaos Labs
Chaos Labs builds financial AI products that power safer, more accessible markets. Its risk management systems, vaults, oracles, and AI platform secure hundreds of billions in value. Since its founding in 2021, Chaos Labs has set the industry standard for onchain risk management.
Photo – https://mma.prnewswire.com/media/2869447/chaos_labs_kraken.jpg
View original content:https://www.prnewswire.co.uk/news-releases/chaos-labs-launches-ai-powered-yield-platform-on-krakens-defi-earn-302670111.html
Exploratory analysis showed favorable patient-reported quality of life outcomes and delayed time to deterioration in…
– Post hoc analysis from pivotal Launch-HTN trial shows statistically significant and clinically meaningful reductions…
– Updated data across two dose levels of 200 mW/cm and 400 mW/cm in LA-PDAC…
This positive CHMP opinion is based on results from the Phase 3 BREAKWATER trial, which…
May 29, 2026 21:18 ET | Source: Fobi AI Inc. VANCOUVER, BC, May 29, 2026…
MONACO, May 29, 2026 (GLOBE NEWSWIRE) -- Crypto news today is turning toward AlphaPepe as…